Stem-Cell Research
Marrow stromal cells selected by serum deprivation express embryonic genes
Published in Hepatitis Weekly, April 19th, 2004
According to a study from the United States, "recently there has been interest in developing cell and gene therapies with adult stem cells from human bone marrow referred to as mesenchymal stem cells or marrow stromal cells (hMSCs). We incubated early-passage hMSCs in serum-free medium without cytokines or other supplements for 2-4 weeks. Surprisingly, a subpopulation of the cells survived serum deprivation and then began to proliferate in serum-containing medium."
"The cells selected by serum deprivation had longer telomeres than control cells," said R.R. Pochampally and...
Want to see the full article?
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Hepatitis Weekly
Source: Hepatitis Weekly (2004-04-19)
More Articles from Hepatitis Weekly
- Hepatitis C Therapy
Forty-eight weeks of therapy may not be long enough for treating HCV type 1 - Immunology
A new immunoassay monitors HCV-infected patients for treatment response - Adverse Drug Effects
Flutamide produces liver toxicity and a death in Germany - Diagnostics
Highly specific probes detect hepatitis C virus in liver tissues - Liver Cancer
Methylated p16 may be a tumor marker for hepatocellular carcinoma - Oncology
Human leukocyte antigen alleles link hepatitis C virus to liver cancer - More from this issue of Hepatitis Weekly
NewsRx is Social
Follow us on your favorite social network by clicking on a button below:
Top Medical Newsletters
Awards
Best Health/Healthcare Content, 2012
Best Health/Healthcare Content, 2011
Best e-Business Site, 2010
Best e-Business Site, 2009
Best e-Business Site, 2008
Best e-Business Site, 2007
Best e-Business Site, 2006
Best Healthcare Content, 2005
Best Overall Internet Site, 2005
Best Interactive Site, 2005
Facts & Stats
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.
- Google 2010 PageRank: #2 Among Top Health News and Media Publications
- Google 2010 PageRank: #2 Among Top Science Publications in Biology/Physiology
- Google 2010 PageRank: #2 Among Top News and Media for the Business of Pharmaceuticals
- Amazon's Alexa 2010 PageRank: #2 News and Media Site for the Pharmaceutical Industry
